Previous studies have suggested that highly metastatic solid tumors, such as prostate, breast, melanoma, and ovarian cancer, constitutively express IL-827–30 and that CTCs present in patient blood samples exhibit highly heterogeneous IL-8 and VEGF secretion profiles15,29. This evidence concerns the gene CXCL8 and ovarian carcinoma.